Combinatorial BMP Ligand Profiles for Selective Cell Activation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for manipulating signaling pathways, such as the Bone Morphogenetic Protein (BMP) pathway, lack specificity and often result in unwanted side effects due to redundant ligand and receptor interactions, making it difficult to achieve targeted cellular responses.
Innovation Solution
The use of specific BMP receptor profiles, such as mouse mammary gland or embryonic stem cell-like profiles, exposed to specific combinations of heterologous BMP ligands like BMP4, BMP9, and GDF5, to induce targeted BMP-dependent responses in cells, while calculating Relative Ligand Strength (RLS) and Ligand Interference Coefficient (LIC) to identify activating ligand combinations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If multiple ligand and receptor variants are used to generate combinatorial signaling complexes, then regulatory flexibility and robustness are improved, but specificity is worsened leading to unwanted side effects
Solution Approach 1:
The patent segments the signaling pathway into distinct functional modules by identifying specific receptor profiles (e.g., NMuMG-like, ESC-like, BMPR1B-overexpressing, ALK1-overexpressing) that respond selectively to particular BMP ligand combinations. This segmentation allows targeted activation of desired cell types while leaving other pathways unaffected, thereby resolving the contradiction between regulatory flexibility and unwanted side effects.
Solution Approach 2:
The patent applies local quality by assigning different responsiveness characteristics to different cell types based on their unique receptor profiles. Each cell type becomes locally optimized to respond to specific ligand combinations, enabling precise spatial and cellular control of signaling activation. This ensures that therapeutic interventions affect only the intended target cells rather than causing system-wide side effects.
2Device complexity
If single ligand and receptor systems are used, then simplicity is improved, but cell type specificity is worsened
Solution Approach 1:
The patent changes the parameter of receptor composition to achieve cell type specificity. By characterizing and exploiting differences in receptor profiles across cell types (NMuMG-like, ESC-like, BMPR1B-overexpressing, ALK1-overexpressing), the system achieves precise targeting without increasing overall complexity. The solution lies in selecting appropriate ligand combinations that match specific receptor profiles rather than simplifying the system further.
Solution Approach 2:
The patent demonstrates universality by showing how a limited set of BMP ligands can universally target multiple cell types when paired with the appropriate ligand combinations. Each ligand combination serves multiple functions: it can activate specific receptor profiles in different cell types while maintaining selectivity. This multi-functionality approach achieves specificity without requiring entirely separate systems for each cell type.
Data Source
AI summary
Methods and compositions are provided for the selective activation of a BMP-dependent response in certain cell types. Methods include identifying a ligand or ligand combinations as well as cell receptor profiles that result in selectively activating a ligand-dependent response through interactions with ligand receptors on a first cell type that do not activate the ligand-dependent response in a second cell type.